Latest filing published 15 May 2008 for JUNIPER PHARMACEUTICALS INC, €8,222.
No signal scores available.
James Scott Crofton has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Juniper Pharmaceuticals Inc and American Mold Guard Inc. We count 12 filings; the first trade dates from 15 May 2006 and the latest from 21 May 2009.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 26 May 2009 came the latest disclosure, a share grant for €137 in Juniper Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations